R
Robert C. Moellering
Researcher at Beth Israel Deaconess Medical Center
Publications - 297
Citations - 24622
Robert C. Moellering is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Antibiotics & Vancomycin. The author has an hindex of 83, co-authored 297 publications receiving 23781 citations. Previous affiliations of Robert C. Moellering include Harvard University & Deaconess Hospital.
Papers
More filters
Journal ArticleDOI
Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.
TL;DR: The effectiveness of cephalosporins in the treatment of experimental infections caused by extended-spectrum beta-lactamase-producing K. pneumoniae may be highly dependent on dosing regimens, even for a specific organism and site of infection.
Journal ArticleDOI
Hemophilus influenzae in hospitalized adults: current perspectives.
TL;DR: In an eight year period 16 cases of serious extrapulmonary Hemophilus influenzae infection in adults were identified, including cases of meningitis, pericarditis, epiglottitis, empyema, cellulitis, osteomyelitis, endometritis, urinary tract infection, orbital cellulitis and primary peritonitis.
Journal ArticleDOI
Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis.
Louis B. Rice,George M. Eliopoulos,Christine Wennersten,Donald A. Goldmann,George A. Jacoby,Robert C. Moellering +5 more
TL;DR: The results indicate that the beta-lactamase genes and gentamicin resistance genes in these strains are integrated into the bacterial chromosome and the cotransmissibility of the resistance determinants raises the possibility of their incorporation into a multiresistance transposable genetic element.
Journal ArticleDOI
Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound.
TL;DR: S-6123 represents a new series of antibacterial agents not related to any other antibacterial compound of natural or synthetic origin and inhibited ribosomal protein synthesis without inhibiting DNA or RNA synthesis, and demonstrated only bacteriostatic activity against susceptible organisms.
Journal ArticleDOI
Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns.
TL;DR: Although both susceptible strains of Streptococcus mitis were identified as S. mitis with identical biochemical profiles, their penicillin-binding protein patterns differed from each other, which may have significance with regard to the need for additional taxonomic classification of the viridans streptococci.